 | Up a level |
Abdullahi, Adam, Fopoussi, Olga Mafotsing, Torimiro, Judith, Atkins, Mark, Kouanfack, Charles and Geretti, Anna Maria 
ORCID: 0000-0002-3670-6588
(2018)
Hepatitis B Virus (HBV) Infection and Re-activation During Nucleos(t)ide Reverse Transcriptase Inhibitor-Sparing Antiretroviral Therapy in a High-HBV Endemicity Setting.
OPEN FORUM INFECTIOUS DISEASES, 5 (10).
Abdullahi, Adam, Fopoussi, Olga Mafotsing, Torimiro, Judith, Atkins, Mark, Kouanfack, Charles and Geretti, Anna Maria ORCID: 0000-0002-3670-6588
(2019)
Hepatitis B Virus (HBV) Infection and Re-activation During Nucleos(t)ide Reverse Transcriptase Inhibitor-Sparing Antiretroviral Therapy in a High-HBV Endemicity Setting (vol 5, ofy251, 2018).
OPEN FORUM INFECTIOUS DISEASES, 6 (4).
Abdullahi, Adam, Beloukas, Apostolos ORCID: 0000-0001-5639-0528, Fopoussi, Olga Mafotsing, Torimiro, Judith, Kouanfack, Charles and Geretti, Anna M ORCID: 0000-0002-3670-6588
(2017)
Risk of hepatitis B virus (HBV) infection and re-activation after discontinuation of tenofovir and/or lamivudine as part of antiretroviral therapy in a high HBV endemicity setting.
.